These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1644152)

  • 1. Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA).
    Lombardi VR; Libonatti O; Alimandi M; Ansotegui I; Scarlatti G; Moschese V; Wigzell H; Rossi P
    Eur J Epidemiol; 1992 Mar; 8(2):298-304. PubMed ID: 1644152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.
    Siitari H; Turunen P; Schrimsher J; Nunn M
    J Clin Microbiol; 1990 Sep; 28(9):2022-9. PubMed ID: 2121790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
    Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
    Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
    Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
    J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of IgA specific antibodies in HIV-1 infected children by peptide-ELISA and peptide time-resolved fluoro-immunoassay.
    Lombardi V; Caniglia M; Scarlatti G; Jansson M; Plebani A; D'Argenio P; Scaccia S; Wigzell H; Rossi P
    Eur J Pediatr; 1993 Jun; 152(6):484-9. PubMed ID: 8335015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.
    Simon F; Souquière S; Damond F; Kfutwah A; Makuwa M; Leroy E; Rouquet P; Berthier JL; Rigoulet J; Lecu A; Telfer PT; Pandrea I; Plantier JC; Barré-Sinoussi F; Roques P; Müller-Trutwin MC; Apetrei C
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):937-52. PubMed ID: 11461679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens.
    Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S
    AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection.
    Morimoto M; Saitoh A; Ueba N; Nakata A; Shinagawa H
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):971-8. PubMed ID: 7506555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1).
    Döpel SH; Porstmann T; Henklein P; von Baehr R
    J Virol Methods; 1989 Aug; 25(2):167-77. PubMed ID: 2476460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.
    Manocha M; Chitralekha KT; Thakar M; Shashikiran D; Paranjape RS; Rao DN
    Immunol Lett; 2003 Feb; 85(3):275-8. PubMed ID: 12663143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA.
    Ellinger S; Mach M; Korn K; Jahn G
    Virology; 1991 Feb; 180(2):811-3. PubMed ID: 1989391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents.
    Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K
    Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells.
    Debiaggi M; Bruno R; Carlevari M; Achilli G; Emanuelli B; Cereda PM; Romero E; Filice G
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):287-96. PubMed ID: 7742042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS.
    Page M; Vella C; Corcoran T; Dilger P; Ling C; Heath A; Thorpe R
    AIDS; 1992 May; 6(5):441-6. PubMed ID: 1616648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.